> Tap -IPV VACCINES) with
 no signif icant interf erence with antibody response toany of the components of either vaccine. However, a trend of lower anti
-HPV GMTs was observed inthe concomitant group. The clinical significance of this observation is not known. This is based on theresults from a clinical trial in which a combined d
> Tap
-IPV vaccine was administered concomitantlywith the first
 dose of GARDASIL (see section
 4.8).The concomitant administration of GARDASIL with VACCINES other than the ones above has not beenstudied.Use with hormonal contraceptives
